Ekso Bionics :: Exoskeleton Technology for Rehabilitation & Personal Mobility

Ekso Bionics is a leading American medical robotics company specializing in exoskeleton technology for rehabilitation and personal mobility. Founded in 2005 and headquartered in San Rafael, California, the company develops and commercializes wearable robotic exoskeletons that help individuals with neurological impairments regain mobility and improve quality of life. Ekso Bionics is widely recognized for pioneering clinical exoskeletons and expanding into personal use devices, with a strong focus on stroke, spinal cord injury (SCI), acquired brain injury, and multiple sclerosis (MS) patients. The company is publicly traded (NYSE: EKSO) and has a global presence with operations in Europe.

Ekso Bionics designs its exoskeletons to augment human strength, balance, and endurance while promoting natural gait patterns and neuroplasticity through repetitive, task-specific training.

Key Robot-Based Products:

• EksoNR: The company’s flagship clinical exoskeleton. It is the only FDA-cleared exoskeleton for use with stroke, acquired brain injury, spinal cord injury, and multiple sclerosis patients. EksoNR uses advanced sensors and algorithms to provide adaptive assistance, helping physical therapists mobilize patients early in recovery and improve walking ability. It is used in over 500 rehabilitation centers worldwide.
• Ekso Indego Personal: A modular, lightweight exoskeleton designed for home and community use. It enables individuals with spinal cord injuries (T3–L5) to stand and walk independently. The system offers Medicare coverage for qualifying beneficiaries and allows users to achieve eye-level interactions and greater independence outside clinical settings.
• Ekso Indego Therapy: A clinical version optimized for outpatient rehabilitation facilities. It supports gait training and strength building for patients with lower extremity weakness or paralysis.

Ekso Bionics continues to innovate in wearable robotics, focusing on user comfort, ease of use, clinical outcomes, and expanding insurance coverage. The company’s technology is supported by strong clinical evidence and aims to bridge the gap between hospital rehabilitation and independent living.